Complete MIRA Stock Valuation Analysis
Comprehensive intrinsic value analysis using 1 different methodologies
MIRA Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 7 peer companies in Healthcare
P/E Ratio
$-29.40
-2245.6%
Peer Median: 61.8x
EV/EBITDA
$0.00
-100.0%
Peer Median: 45.1x
P/S Ratio
$1.95
+42.6%
Peer Median: 3.0x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for MIRA's business model and current situation.
Multiple Comparison
| Multiple | MIRA Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -2.9x | 61.8x | 61.8x | -104.7% | Undervalued |
| EV/EBITDA | Infinityx | 45.1x | 45.1x | Infinity% | Overvalued |
| P/S Ratio | 2.1x | 3.0x | 6.6x | -29.9% | Undervalued |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $0.03B | 0.0x | 0.0x | 3.0x | |
| $0.02B | 0.0x | 0.0x | 0.0x | |
| $0.03B | 0.0x | 0.0x | 0.0x | |
| $0.02B | 0.0x | 0.0x | 2.1x | |
| $0.03B | 0.0x | 0.0x | 0.0x | |
| $0.02B | 0.0x | 0.0x | 703.9x | |
| $722.17B | 61.8x | 45.1x | 14.7x |